List view / Grid view
28 May 2015 | By Victoria White
Seres Therapeutics has enrolled and dosed the first patient in its Phase 2 clinical study of SER-109 in recurrent CDI in adults...
28 May 2015 | By Victoria White
ESMO, in collaboration with EORTC, have expressed their views on the EU Clinical Trials Regulation in an official position paper...
28 May 2015 | By Victoria White
Pfizer has announced initial results of its global NarRAtive survey of more than 3,600 adults with rheumatoid arthritis in 13 countries...
28 May 2015 | By Victoria White
Top line results have been announced from the GS-4774 Phase 2 study in patients with HBV on long term viral suppression with an oral antiviral treatment...
28 May 2015 | By Victoria White
A trial has found that HIV-infected individuals have a lower risk of developing AIDS or other serious illnesses if given antiretroviral drugs sooner...
28 May 2015 | By TA Instruments
TA Instruments announced the acquisition of certain assets related to the Bose ElectroForce Group, from the Bose Corporation of Framingham Massachusetts...
28 May 2015 | By Victoria White
The US Food and Drug Administration has approved Boehringer Ingelheim’s once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray...
28 May 2015 | By Victoria White
The pharmaceuticals sector is celebrating a triple win following the 2014/15 European Business Awards exclusive awards ceremony in London...
27 May 2015 | By Victoria White
The CHMP has recommended approval of STELARA for the treatment of moderate to severe plaque psoriasis in adolescent patients aged 12 and older...
27 May 2015 | By Victoria White
The SCALE Obesity and Prediabetes trial met its primary endpoint, demonstrating that ongoing treatment with Saxenda delayed the onset of type 2 diabetes...
27 May 2015 | By Victoria White
Primary results from a Phase 3 study demonstrates a significantly higher DRR in patients with metastatic melanoma receiving the talimogene laherparepvec...
27 May 2015 | By Victoria White
The EC has granted marketing authorisation for tolvaptan for the treatment of ADPKD in adults who have chronic kidney disease (CKD)...
27 May 2015 | By Victoria White
The global market value for advanced wound dressings will increase to reach $3.51 billion by 202, according to research and consulting firm GlobalData...
27 May 2015 | By Victoria White
Helsinn Group has announced that the European Commission has approved ALOXI injection for the prevention of acute CINV in children aged one to six months...
27 May 2015 | By Victoria White
Eisai has received a positive opinion from the EMA’s CHMP for the use of Fycompa for the adjunctive treatment of PGTC seizures...
